AASTROM BIOSCIENCES, INC. 15,943,750 Shares of Common Stock, no par value per share PLACEMENT AGENCY AGREEMENT April 6, 2006
EXHIBIT 99.1
AASTROM BIOSCIENCES, INC.
15,943,750 Shares of Common Stock, no par value per share
April
6, 2006
Xxxxxxxx Curhan Ford & Co.
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Dear Sir or Madam:
Aastrom Biosciences, Inc., a Michigan corporation (the “Company”), proposes to issue and sell
15,943,750 shares (the “Shares”) of common stock, no par value per share (the “Common Stock”),
to certain investors (collectively, the “Investors”). The Company desires to engage you as its
placement agent (the “Placement Agent”) in connection with such issuance and sale. The Shares are
more fully described in the Registration Statement (as hereinafter defined).
The Company hereby confirms as follows its agreements with the Placement Agent.
1. Agreement to Act as Placement Agent. On the basis of the representations,
warranties and agreements of the Company herein contained and subject to all the terms and
conditions of this Agreement, the Placement Agent agrees to act as the Company’s exclusive
placement agent in connection with the issuance and sale, on a best efforts basis, by the Company
of the Shares to the Investors. The Company shall pay to the
Placement Agent 6.00% of the proceeds
received by the Company from the sale of the Shares as set forth on the cover page of the
Prospectus (as hereinafter defined).
2.
Delivery and Payment. At 10:00 a.m., New York City time,
on April 11, 2006, or at
such other time on such other date as may be agreed upon by the Company and the Placement Agent
(such date is hereinafter referred to as the “Closing Date”), the Placement Agent shall cause the
Investors to wire an amount equal to the price per Share as shown on the cover page of the
Prospectus (as hereinafter defined) multiplied by the number of Shares purchased by it to an
account designated by the Company and the Company shall deliver the Shares to the Investors, which
delivery may be made through the facilities of the Depository Trust Company. The closing (the
“Closing”) shall take place at the office of Xxxxxxxx & Xxxxxxxx LLP at 0000 Xxxxxx xx xxx
Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000. All actions taken at the Closing shall be deemed to have
occurred simultaneously.
3. Representations and Warranties of the Company. The Company represents and warrants
and covenants to the Placement Agent that:
(a) The Company has filed with the Securities and Exchange Commission (the “Commission”) a
“shelf” registration statement on Form S-3 (Registration No. 333-123570), which has become
effective, relating to the Common Stock and certain other securities of the Company, under the
Securities Act of 1933, as amended (the “Act”), and the rules and regulations (collectively
referred to as the “Rules and Regulations”) of the Commission promulgated thereunder. As used in
this Agreement:
(i) “Applicable Time” means 9:00 a.m. (New York City time) on the date of this
Agreement;
(ii) “Effective Date” means any date as of which any part of the Registration Statement
became, or is deemed to have become, effective under the Act in accordance with the Rules and
Regulations;
(iii) “Issuer Free Writing Prospectus” means each “free writing prospectus” (as defined in
Rule 405 of the Rules and Regulations) prepared by or on behalf of the Company or used or referred
to by the Company in connection with the offering of the Shares;
(iv) “Preliminary Prospectus” means any preliminary prospectus relating to the Shares
included in the Registration Statement or filed with the Commission pursuant to Rule 424(b) of the
Rules and Regulations, including any preliminary prospectus supplement thereto relating to the
Shares;
(v) “Pricing Disclosure Materials” means, as of the Applicable Time, the most recent
Preliminary Prospectus, together with each Issuer Free Writing Prospectus filed or used by the
Company on or before the Applicable Time;
(vi) “Prospectus” means the final prospectus relating to the Shares including any prospectus
supplement thereto relating to the Shares, as filed with the Commission pursuant to Rule 424(b) of
the Rules and Regulations; and
(vi) “Registration Statement” means, collectively, the various parts of such registration
statement, each as amended as of the Effective Date for such part, including any Preliminary
Prospectus or the Prospectus and all exhibits to such registration statement.
Any reference to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and
include any documents incorporated or deemed to be incorporated by reference therein pursuant to
Form S-3 under the Act as of the date of such Preliminary Prospectus or the Prospectus, as the case
may be. Any reference herein to the terms “amend”, “amendment” or “supplement” with respect to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include any document filed under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), after the effective date of the Registration Statement, the date of such Preliminary
Prospectus or the date of the Prospectus, as the case may be, which is incorporated therein by
reference.
2
(b) The Registration Statement has heretofore become effective under the Act or, with respect
to any registration statement to be filed to register the offer and sale of Shares pursuant to Rule
462(b) under the Act, will be filed with the Commission and become effective under the Act no later
than 10:00 p.m., New York City time, on the date of determination of the public offering price for
the Shares; no stop order of the Commission preventing or suspending the use of any Prospectus, or
the effectiveness of the Registration Statement, has been issued, and no proceedings for such
purpose have been instituted or, to the Company’s knowledge, are contemplated by the Commission.
(c) The Company was not at the time of initial filing of the Registration Statement, has not
been since the date of such filing, and will not be on the applicable Closing Date, an “ineligible
issuer” (as defined in Rule 405 under the Act). The Company has been since the time of initial
filing of the Registration Statement and continues to be eligible to use Form S-3 for the offering
of the Shares.
(d) The Registration Statement, at the time it became effective, as of the date hereof, and at
the Closing Date conformed and will conform in all material respects to the requirements of the Act
and the Rules and Regulations. The Preliminary Prospectus conformed, and the Prospectus will
conform, when filed with the Commission pursuant to Rule 424(b) and on the Closing Date to the
requirements of the Act and the Rules and Regulations. The documents incorporated by reference in
any Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated
will conform, when filed with the Commission, to the requirements of the Exchange Act or the Act,
as applicable, and the rules and regulations of the Commission thereunder.
(e) The Registration Statement did not, as of the Effective Date, contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading.
(f) The Prospectus will not, as of its date and on the Closing Date, contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that the Company makes no representation
or warranty with respect to any statement contained in the Prospectus in reliance upon and in
conformity with information concerning the Placement Agent and furnished in writing by the
Placement Agent to the Company expressly for use in the Prospectus, as set forth in Section 8(b).
(g) The documents incorporated by reference in any Preliminary Prospectus or the Prospectus
did not, and any further documents filed and incorporated by reference therein will not, when filed
with the Commission, contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading.
(h) The Pricing Disclosure Materials did not, as of the Applicable Time, contain an untrue
statement of a material fact or omit to state a material fact required to
3
be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, except that the price of the Shares, number of Shares
to be sold, and disclosures directly relating thereto will be included on the cover page of the
Prospectus; provided, however, that the Company makes no representation or warranty
with respect to any statement contained in the Pricing Disclosure Materials in reliance upon and in
conformity with information concerning the Placement Agent and furnished in writing by the
Placement Agent to the Company expressly for use in the Pricing Disclosure Materials, as set forth
in Section 8(b).
(i) Each Issuer Free Writing Prospectus (including, without limitation, any road show that is
a free writing prospectus under Rule 433), when considered together with the Pricing Disclosure
Materials as of the Applicable Time, did not contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading, except that the price of
the Shares, number of Shares to be sold, and disclosures directly relating thereto will be included
on the cover page of the Prospectus.
(j) Each Issuer Free Writing Prospectus conformed or will conform in all material respects to
the requirements of the Act and the Rules and Regulations on the date of first use, and the Company
has complied with any filing requirements applicable to such Issuer Free Writing Prospectus
pursuant to the Rules and Regulations. The Company has not made any offer relating to the Shares
that would constitute an Issuer Free Writing Prospectus without the prior written consent of the
Placement Agent, except as set forth on Schedule 1 hereto. The Company has retained in accordance
with the Rules and Regulations all Issuer Free Writing Prospectuses that were not required to be
filed pursuant to the Rules and Regulations.
(k) The Company is, and at the Closing Date will be, duly organized, validly existing and in
good standing under the laws of the State of Michigan. The Company has, and at the Closing Date
will have, full power and authority to conduct all the activities conducted by it, to own or lease
all the assets owned or leased by it and to conduct its business as described in the Registration
Statement and the Prospectus. The Company is, and at the Closing Date will be, duly licensed or
qualified to do business and in good standing as a foreign organization in all jurisdictions in
which the nature of the activities conducted by it or the character of the assets owned or leased
by it makes such licensing or qualification necessary, except where the failure to be so qualified
or in good standing or have such power or authority would not, individually or in the aggregate,
have a material adverse effect or would not reasonably be expected to have a material adverse
effect on or affecting the business, prospects, properties, management, consolidated financial
position, stockholders’ equity or results of operations of the Company and its Subsidiaries (as
defined below) taken as a whole (a “Material Adverse Effect”). Complete and correct copies of the
articles or certificate of incorporation and of the bylaws of the Company and all amendments
thereto have been delivered to the Placement Agent, and no changes therein will be made subsequent
to the date hereof and prior to the Closing Date.
(l) The Company’s only active subsidiaries (each a “Subsidiary” and collectively the
“Subsidiaries”) are listed on Schedule 2 to this Agreement. Each Subsidiary
4
has been duly organized and is validly existing as a corporation in good standing under the
laws of its jurisdiction of formation. Each Subsidiary is duly qualified and in good standing as a
foreign corporation in each jurisdiction in which the character or location of its properties
(owned, leased or licensed) or the nature or conduct of its business makes such qualification
necessary, except for those failures to be so qualified or in good standing which will not have a
Material Adverse Effect. All of the shares of issued capital stock of each subsidiary of the
Company which has completed its formation process have been duly authorized and validly issued, are
fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear
of any lien, encumbrance, claim, security interest, restriction on transfer, shareholders’
agreement, voting trust or other defect of title whatsoever.
(m) The issued and outstanding shares of capital stock of the Company have been validly
issued, are fully paid and nonassessable and, other than as set forth in the Registration
Statement, are not subject to any preemptive rights, rights of first refusal or similar rights.
The Company has an authorized, issued and outstanding capitalization as set forth in the Prospectus
as of the dates referred to therein. The descriptions of the securities of the Company in the
Registration Statement and the Prospectus are, and at the Closing Date will be, complete and
accurate in all respects. Except as set forth in the Registration Statement and the Prospectus and
for (i) awards under the Company’s equity incentive plans granted after the respective date thereof
and (ii) ongoing offers and sales under the Company’s Direct Stock Purchase Plan, the Company does
not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any
securities or obligations convertible into, or exchangeable for, or any contracts or commitments to
issue or sell, any shares of capital stock or other securities.
(n) The Company has full legal right, power and authority to enter into this Agreement and
perform the transactions contemplated hereby and thereby. This Agreement has been authorized and
validly executed and delivered by the Company and is a legal, valid and binding agreement of the
Company enforceable against the Company in accordance with its respective terms, subject to the
effect of applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally
and equitable principles of general applicability.
(o) The issuance and sale of the Shares have been duly authorized by the Company, and the
Shares, when issued and paid for in accordance with this Agreement, will be duly and validly
issued, fully paid and nonassessable and will not be subject to preemptive or similar rights. The
holders of the Shares will not be subject to personal liability by reason of being such holders.
The Shares, when issued, will conform in all material respects to the description thereof set forth
in or incorporated into the Prospectus.
(p) The consolidated financial statements and the related notes included in the Registration
Statement and the Prospectus present fairly, in all material respects, the financial condition of
the Company and its consolidated Subsidiaries as of the dates thereof and the results of operations
and cash flows at the dates and for the periods covered thereby in conformity with generally
accepted accounting principles (“GAAP”). No other financial statements or schedules of the
Company, any Subsidiary or any other entity are
5
required by the Act or the Rules and Regulations to be included in the Registration Statement
or the Prospectus.
(q) PricewaterhouseCoopers LLP (the “Accountants”), who have reported on such consolidated
financial statements and schedules, are registered independent public accountants with respect to
the Company as required by the Act and the Rules and Regulations and by the rules of the Public
Accounting Oversight Board. The consolidated financial statements of the Company and the related
notes and schedules included in the Registration Statement and the Prospectus have been prepared in
conformity with the requirements of the Act and the Rules and Regulations and present fairly the
information shown therein.
(r) The Company is, and at the Closing Date will be, in compliance with all provisions of the
Xxxxxxxx-Xxxxx Act of 2002, as amended, which are applicable to it. The Company and each
Subsidiary maintain a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to maintain
accountability for assets; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.
(s) The Company and its Subsidiaries maintain systems of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. The Company has established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
Company and designed such disclosure controls and procedures to ensure that material information
relating to the Company and its Subsidiaries is made known to the certifying officers by others
within those entities, particularly during the period in which the Company’s Annual Report on Form
10-K or Quarterly Report on Form 10-Q, as the case may be, is being prepared. The Company’s
certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of
the end of the period covered by the Form 10-Q for the quarter ended December 31, 2005 (such date,
the “Evaluation Date”). The Company presented in its Form 10-Q for the quarter ended December 31,
2005 the conclusions of the certifying officers about the effectiveness of the disclosure controls
and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date,
there have been no significant changes in the Company’s internal controls (as such term is defined
in Item 307(b) of Regulation S-K under the Exchange Act) or, to the Company’s knowledge, in other
factors that could significantly affect the Company’s internal controls.
6
(t) Except as set forth in or otherwise contemplated by the most recent Preliminary
Prospectus, since the later of December 31, 2005 or the date of the most recent consolidated
financial statements of the Company included or incorporated by reference in the most recent
Preliminary Prospectus and prior to Closing, (i) there has not been and will not have been any
change in the capital stock of the Company (except for changes in the number of outstanding shares
of Common Stock of the Company due to the issuance of shares upon the exercise of stock options or
warrants or upon the grant of restricted stock to the Company’s directors and new employees and the
issuance of shares pursuant to the Company’s Direct Stock Purchase Plan) or long-term debt of the
Company or any Subsidiary or any dividend or distribution of any kind declared, set aside for
payment, paid or made by the Company on any class of capital stock, or any material adverse change,
or any development that would reasonably be expected to result in a material adverse change, in or
affecting the business, prospects, properties, management, consolidated financial position,
stockholders’ equity, or results of operations of the Company and its Subsidiaries taken as a whole
(a “Material Adverse Change”) and (ii) neither the Company nor any Subsidiary has sustained any
material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor disturbance or dispute or any action, order
or decree of any court or arbitrator or governmental or regulatory authority, except in each case
as otherwise disclosed in the Registration Statement and the Prospectus.
(u) Since the later of December 31, 2005 or the date as of which information is given in the
most recent Preliminary Prospectus, neither the Company nor any Subsidiary has entered or will
enter into any transaction or agreement, not in the ordinary course of business, that is material
to the Company and its Subsidiaries taken as a whole or incurred or will incur any liability or
obligation, direct or contingent, not in the ordinary course of business, that is material to the
Company and its Subsidiaries taken as a whole.
(v) The Company and each Subsidiary has good and valid title in fee simple to all items of
real property and good and valid title to all personal property described in the Registration
Statement or the Prospectus as being owned by them that are material to the businesses of the
Company and its Subsidiaries taken as a whole, in each case free and clear of all liens,
encumbrances and claims except those that (i) do not materially interfere with the use made and
proposed to be made of such property by the Company and its Subsidiaries or (ii) would not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Any
real property described in the Registration Statement or the Prospectus as being leased by the
Company or any Subsidiary that is material to the business of the Company and its Subsidiaries
taken as a whole is held by them under valid, existing and enforceable leases, except those that
(A) do not materially interfere with the use made or proposed to be made of such property by the
Company and its Subsidiaries or (B) would not be reasonably expected, individually or in the
aggregate, to have a Material Adverse Effect.
(w) The Company is not, nor upon completion of the transactions contemplated herein will it
be, an “investment company” or an “affiliated person” of, or “promoter” or “principal underwriter”
for, an “investment company,” as such terms are defined in the Investment Company Act of 1940, as
amended (the “Investment Company Act”).
7
(x) There are no legal, governmental or regulatory actions, suits or proceedings pending, nor,
to the Company’s knowledge, any legal, governmental or regulatory investigations, to which the
Company or any Subsidiary is a party or to which any property of the Company or any Subsidiary is
the subject that, individually or in the aggregate, if determined adversely to the Company or any
Subsidiary, would reasonably be expected to have a Material Adverse Effect or materially and
adversely affect the ability of the Company to perform its
obligations under this Agreement; to the Company’s knowledge, no such actions, suits or proceedings are threatened or
contemplated by any governmental or regulatory authority or threatened by others; and there are no
current or pending legal, governmental or regulatory investigations, actions, suits or proceedings
that are required under the Act to be described in the Prospectus that are not so described.
(y) The Company and each Subsidiary has, and at the Closing Date will have, (i) all
governmental licenses, permits, consents, orders, approvals and other authorizations necessary to
carry on its respective business as presently conducted except where the failure to have such
governmental licenses, permits, consents, orders, approvals and other authorizations would not have
a Material Adverse Effect, (ii) complied with all laws, regulations and orders applicable to either
it or its business, except where the failure to so comply would not have a Material Adverse Effect,
and (iii) performed all its obligations required to be performed, and is not, and at the Closing
Date will not be, in default, under any indenture, mortgage, deed of trust, voting trust agreement,
loan agreement, bond, debenture, note agreement, lease, contract or other agreement or instrument
(collectively, a “contract or other agreement”) to which it is a party or by which its property is
bound or affected, except where such default would not have a Material Adverse Effect, and, to the
Company’s best knowledge, no other party under any material contract or other agreement to which it
is a party is in default in any respect thereunder. The Company and its Subsidiaries are not in
violation of any provision of their respective organizational or governing documents.
(z) The
Company has all corporate power and authority to enter into this
Agreement,
and to carry out the provisions and conditions hereof and thereof, and all consents,
authorizations, approvals and orders required in connection herewith and therewith have been
obtained, except such as have been obtained, such as may be required under state securities or Blue
Sky Laws or the by-laws and rules of the National Association of Securities Dealers, Inc. (the
“NASD”) or the Nasdaq Capital Market in connection with the purchase and distribution of the Shares
by the Placement Agent.
(aa)
Neither the execution of this Agreement, nor the issuance, offering or sale of
the Shares, nor the consummation of any of the transactions contemplated herein, nor the compliance
by the Company with the terms and provisions hereof or thereof will conflict with, or will result
in a breach of, any of the terms and provisions of, or has constituted or will constitute a default
under, or has resulted in or will result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any Subsidiary pursuant to the terms of
any contract or other agreement to which the Company or its Subsidiaries may be bound or to which
any of the property or assets of the Company or its Subsidiaries is subject, except such conflicts,
breaches or defaults as may have been waived; nor will such action result in any violation of the
provisions of the organizational
8
or governing documents of the Company or any Subsidiary, or any statute or any order, rule or
regulation applicable to the Company or any Subsidiary or of any court or of any federal, state or
other regulatory authority or other government body having jurisdiction over the Company or any
Subsidiary.
(bb) There is no document or contract of a character required to be described in the
Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement
which is not described or filed as required. All such contracts to which the Company is a party
have been authorized, executed and delivered by the Company, constitute valid and binding
agreements of the Company, and are enforceable against the Company in accordance with the terms
thereof, subject to the effect of applicable bankruptcy, insolvency or similar laws affecting
creditors’ rights generally and equitable principles of general applicability.
(cc) No statement, representation or warranty made by the Company in this Agreement or made in
any certificate or document required by this Agreement to be delivered to the Placement
Agent or the Investors was or will be, when made, inaccurate, untrue or incorrect in any material
respect.
(dd) The Company and its directors, officers or controlling persons have not taken, directly
or indirectly, any action intended, or which might reasonably be expected, to cause or result,
under the Act or otherwise, in, or which has constituted, stabilization or manipulation of the
price of any security of the Company to facilitate the sale or resale of the Common Stock.
(ee) No holder of securities of the Company has rights to the registration of any securities
of the Company as a result of the filing of the Registration Statement or the transactions
contemplated by this Agreement, except for such rights as have been waived or satisfied.
(ff) The Common Stock is currently listed on the Nasdaq Capital Market. The Company has not,
in the 12 months preceding the date hereof, received notice from the Nasdaq Capital Market to the
effect that the Company is not in compliance with the listing or maintenance requirements. The
Company is, and has no reason to believe that it will not in the foreseeable future continue to be,
in compliance with all such listing and maintenance requirements.
(gg) The Company is not involved in any material labor dispute nor is any such dispute known
by the Company to be threatened.
(hh) The business and operations of the Company and each of its Subsidiaries have been and are
being conducted in compliance with all applicable laws, ordinances, rules, regulations, licenses,
permits, approvals, plans, authorizations or requirements relating to occupational safety and
health, or pollution, or protection of health or the environment (including, without limitation,
those relating to emissions, discharges, releases or threatened releases of pollutants,
contaminants or hazardous or toxic substances, materials or wastes into ambient air, surface water,
groundwater or land, or relating to the manufacture,
9
processing, distribution, use, treatment, storage, disposal, transport or handling of chemical
substances, pollutants, contaminants or hazardous or toxic substances, materials or wastes, whether
solid, gaseous or liquid in nature) of any governmental department, commission, board, bureau,
agency or instrumentality of the United States, any state or political subdivision thereof, or any
foreign jurisdiction, and all applicable judicial or administrative agency or regulatory decrees,
awards, judgments and orders relating thereto, except where the failure to be in such compliance
will not, individually or in the aggregate, have a Material Adverse Effect; and neither the Company
nor any of its Subsidiaries has received any notice from any governmental instrumentality or any
third party alleging any material violation thereof or liability thereunder (including, without
limitation, liability for costs of investigating or remediating sites containing hazardous
substances and/or damages to natural resources).
(ii) The Company and each Subsidiary owns, is licensed or otherwise possesses all rights to
use, all patents, patent rights, inventions, know-how (including trade secrets and other unpatented
or unpatentable or confidential information, systems, or procedures), trademarks, service marks,
trade names, copyrights and other intellectual property rights (collectively, the “Intellectual
Property”) necessary for the conduct of its business as described in the Registration Statement.
No claims have been asserted against the Company or any of its Subsidiaries by any person with
respect to the use of any such Intellectual Property or challenging or questioning the validity or
effectiveness of any such Intellectual Property.
(jj) The Company and each Subsidiary has filed all necessary federal, state and foreign income
and franchise tax returns and have paid or accrued all taxes shown as due thereon, and the Company
has no knowledge of any tax deficiency which has been or might be asserted or threatened against it
or any Subsidiary which could have a Material Adverse Effect.
(kk) On the Closing Date, all stock transfer or other taxes (other than income taxes) which
are required to be paid in connection with the sale and transfer of the Shares to be sold hereunder
will be, or will have been, fully paid or provided for by the Company and all laws imposing such
taxes will be or will have been fully complied with.
(ll) The Company and each Subsidiary maintains insurance of the types and in the amounts that
the Company reasonably believes is adequate for their respective businesses, including, but not
limited to, insurance covering all real and personal property owned or leased by the Company or any
Subsidiary against theft, damage, destruction, acts of vandalism and all other risks customarily
insured against by similarly situated companies, all of which insurance is in full force and
effect.
(mm) Neither the Company nor any Subsidiary, nor, to the knowledge of the Company, any
director, officer, agent or employee has directly or indirectly, (i) made any unlawful contribution
to any candidate for public office, or failed to disclose fully any contribution in violation of
law, (ii) made any payment to any federal or state governmental officer or official, or other
person charged with similar public or quasi-public duties, other than payments required or
permitted by the laws of the United States or any jurisdiction thereof, (iii)
10
violated or is in violation of any provisions of the U.S. Foreign Corrupt Practices Act of
1977 or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment.
(nn) Each officer and director of the Company listed on Schedule 3 hereto has delivered to the
Placement Agent an agreement in the form of Exhibit A hereto to the effect that he or she will not,
for a period of 90 days after the date hereof, without the prior written consent of the Placement
Agent, offer to sell, sell, contract to sell, grant any option to purchase or otherwise dispose (or
announce any offer, sale, grant of any option to purchase or other disposition) of any shares of
capital stock, directly or indirectly, of the Company or securities convertible into, or
exchangeable or exercisable for, shares of capital stock of the Company.
(oo) The Company has delivered to the Placement Agent an agreement in the form of Exhibit B
hereto to the effect that it will not, for a period of 60 days after the date hereof, without the
prior written consent of the Placement Agent, offer to sell, sell, contract to sell, grant any
option to purchase or otherwise dispose (or announce any offer, sale, grant of any option to
purchase or other disposition) of any shares of capital stock of the Company or securities
convertible into, or exchangeable or exercisable for, shares of capital stock of the Company,
except with respect to the issuance of (i) shares of Common Stock upon the exercise of stock options
and warrants outstanding as of the date hereof, (ii) shares or stock
options under any benefit plan of the Company, (iii) shares pursuant to the Company’s
Direct Stock Purchase Plan and (iv) securities of the Company, including stock options, to a new
Chief Executive Officer of the Company appointed after the date hereof (provided that such
securities shall be subject to the same restrictions as indicated in the agreement in the form of
Exhibit A hereto for the balance, if any, of the 90 period after the date hereof).
(pp) The Company has not distributed and, prior to the later to occur of the Closing Date and
completion of the distribution of the Shares, will not distribute any offering material in
connection with the offering and sale of the Shares other than any Preliminary Prospectus, the
Prospectus, any Issuer Free Writing Prospectus to which the Placement Agent has consented and any
Issuer Free Writing Prospectus set forth on Schedule 1 hereto.
(qq) Each material employee benefit plan, within the meaning of Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained, administered or
contributed to by the Company or any of its affiliates for employees or former employees of the
Company and its Subsidiaries has been maintained in material compliance with its terms and the
requirements of any applicable statutes, orders, rules and regulations, including but not limited
to ERISA and the Internal Revenue Code of 1986, as amended (the “Code”); no prohibited transaction,
within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would
result in a material liability to the Company with respect to any such plan excluding transactions
effected pursuant to a statutory or administrative exemption; and for each such plan that is
subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no “accumulated
funding deficiency” as defined in Section 412 of the Code has been incurred,
11
whether or not waived, and the fair market value of the assets of each such plan (excluding
for these purposes accrued but unpaid contributions) exceeds the present value of all benefits
accrued under such plan determined using reasonable actuarial assumptions.
(rr) No relationship, direct or indirect, exists between or among the Company or any
Subsidiary, on the one hand, and the directors, officers, stockholders, customers or suppliers of
the Company or any Subsidiary, on the other, which is required by the Act to be disclosed in the
Registration Statement and the Prospectus and is not so disclosed.
(ss) The Company has not sold or issued any securities that would be integrated with the
offering of the Shares contemplated by this Agreement pursuant to the Act, the Rules and
Regulations or the interpretations thereof by the Commission.
(tt) No forward-looking statement (within the meaning of Section 27A of the Securities Act and
Section 21E of the Exchange Act) (a “Forward Looking Statement”) contained in the Registration
Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been
disclosed other than in good faith. The Forward Looking Statements incorporated by reference in
the Registration Statement and the Prospectus from the Company’s Annual Report on Form 10-K for the
year ended June 30, 2005 and Quarterly Reports on Form 10-Q for the periods ending September 30,
2005 and December 31, 2005 (in each case under the heading “Management’s Discussion and Analysis of
Financial Condition and Results of Operations) (i) are within the coverage of the safe harbor for
forward looking statements set forth in Section 27A of the Act, Rule 175(b) under the Act or Rule
3b-6 under the Exchange Act, as applicable, (ii) were made by the Company with a reasonable basis
and in good faith and reflect the Company’s good faith reasonable best estimate of the matters
described therein, and (iii) have been prepared in accordance with Item 10 of Regulation S-K under
the Act.
(uu) Neither the Company nor its Subsidiaries are a party to any contract, agreement or
understanding with any person (other than this Agreement) that would give rise to a valid claim
against the Company or its Subsidiaries or the Placement Agent for a brokerage commission, finder’s
fee or like payment in connection with the offering and sale of the Shares.
4. Agreements of the Company. The Company covenants and agrees with the Placement
Agent as follows:
(a) The Registration Statement has become effective, and if Rule 430A is used or the filing of
the Prospectus is otherwise required under Rule 424(b), the Company will file the Prospectus
(properly completed if Rule 430A has been used), subject to the prior approval of the Placement
Agent, pursuant to Rule 424(b) within the prescribed time period and will provide a copy of such
filing to the Placement Agent promptly following such filing.
(b) The Company will not, during such period as the Prospectus would be required by law to be
delivered in connection with sales of the Shares by an underwriter or dealer in connection with the
offering contemplated by this Agreement, file any
12
amendment or supplement to the Registration Statement or the Prospectus unless a copy thereof
shall first have been submitted to the Placement Agent within a reasonable period of time prior to
the filing thereof and the Placement Agent shall not have reasonably objected thereto in good
faith.
(c) The Company will notify the Placement Agent promptly, and will, if requested, confirm such
notification in writing, (1) when any post-effective amendment to the Registration Statement
becomes effective, but only during the period mentioned in Section 4(b); (2) of any request by the
Commission for any amendments to the Registration Statement or any amendment or supplements to the
Prospectus or any Issuer Free Writing Prospectus or for additional information, but only during the
period mentioned in Section 4(b); (3) of the issuance by the Commission of any stop order
preventing or suspending the effectiveness of the Registration Statement, the Prospectus or any
Issuer Free Writing Prospectus, or the initiation of any proceedings for that purpose or the threat
thereof, but only during the period mentioned in Section 4(b); (4) of becoming aware of the
occurrence of any event during the period mentioned in Section 4(b) that in the judgment of the
Company makes any statement made in the Registration Statement or the Prospectus untrue in any
material respect or that requires the making of any changes in the Registration Statement or the
Prospectus in order to make the statements therein, in light of the circumstances in which they are
made, not misleading; and (5) of receipt by the Company of any notification with respect to any
suspension of the qualification of the Shares for offer and sale in any jurisdiction. If at any
time the Commission shall issue any order suspending the effectiveness of the Registration
Statement in connection with the offering contemplated hereby, the Company will make every
reasonable effort to obtain the withdrawal of any such order at the earliest possible moment. If
the Company has omitted any information from the Registration Statement, pursuant to Rule 430A, it
will use its best efforts to comply with the provisions of and make all requisite filings with the
Commission pursuant to said Rule 430A and to notify the Placement Agent promptly of all such
filings.
(d) If, at any time when a Prospectus relating to the Shares is required to be delivered under
the Act, the Company becomes aware of the occurrence of any event as a result of which the
Prospectus, as then amended or supplemented, would, in the reasonable judgment of counsel to the
Company or counsel to the Placement Agent, include any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, or the Registration Statement, as then
amended or supplemented, would, in the reasonable judgment of counsel to the Company or counsel to
the Placement Agent, include any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein not misleading, or if for any other reason it is
necessary, in the reasonable judgment of counsel to the Company or counsel to the Placement Agent,
at any time to amend or supplement the Prospectus or the Registration Statement to comply with the
Act or the Rules and Regulations, the Company will promptly notify the Placement Agent and, subject
to Section 4(b) hereof, will promptly prepare and file with the Commission, at the Company’s
expense, an amendment to the Registration Statement or an amendment or supplement to the Prospectus
that corrects such statement or omission or effects such compliance and will deliver to the
Placement Agent, without charge, such number of copies thereof as the Placement Agent
13
may reasonably request. The Company consents to the use of the Prospectus or any amendment or
supplement thereto by the Placement Agent.
(e) The Company will furnish to the Placement Agent and its counsel, without charge (i) one
conformed copy of the Registration Statement as originally filed with the Commission and each
amendment thereto, including financial statements and schedules, and all exhibits thereto, (ii) so
long as a prospectus relating to the Shares is required to be delivered under the Act, as many
copies of each Issuer Free Writing Prospectus, Preliminary Prospectus or the Prospectus or any
amendment or supplement thereto as the Placement Agent may reasonably request.
(f) The Company will make generally available to its securityholders, as soon as it is
practicable to do so, but in any event not later than 15 months after the effective date of the
Registration Statement, an earnings statement (which need not be audited) in reasonable detail,
covering a period of at least 12 consecutive months beginning after the effective date of the
Registration Statement, which earnings statement shall satisfy the requirements of Section 11(a) of
the Act and Rule 158 under the Act and will advise you in writing when such statement has been so
made available.
(g) The Company will comply with all the undertakings contained in the Registration Statement.
(h) The Company will not make any offer relating to the Shares that would constitute an Issuer
Free Writing Prospectus without the prior written consent of the Placement Agent.
(i) The Company will retain in accordance with the Rules and Regulations all Issuer Free
Writing Prospectuses not required to be filed pursuant to the Rules and Regulations.
(j) Prior to the sale of the Shares to the Investors, the Company will cooperate with the
Placement Agent and its counsel in connection with the registration or qualification of the Shares
for offer and sale under the state securities or Blue Sky laws of such jurisdictions as the
Placement Agent may reasonably request; provided, that in no event shall the Company be obligated
to qualify to do business in any jurisdiction where it is not now so qualified or to take any
action which would subject it to general service of process in any jurisdiction where it is not now
so subject.
(k) The Company will apply the net proceeds from the offering and sale of the Shares in the
manner set forth in the Prospectus under the caption “Use of Proceeds.”
(l) The Company will use its best efforts to ensure that the Shares are listed or quoted on
the Nasdaq Capital Market at the time of the Closing.
(m) The Company will not at any time, directly or indirectly, take any action intended, or
which might reasonably be expected, to cause or result in, or which will
14
constitute, stabilization of the price of the Shares to facilitate the sale or resale of any
of the Shares.
5. Agreements of the Placement Agent. The Placement Agent agrees that it shall not
include any “issuer information” (as defined in Rule 433 under the Act) in any “free writing
prospectus” (as defined in Rule 405) used or referred to by such Placement Agent without the prior
consent of the Company (any such issuer information with respect to whose use the Company has given
its consent, “Permitted Issuer Information”); provided that (i) no such consent shall be required
with respect to any such issuer information contained in any document filed by the Company with the
Commission prior to the use of such free writing prospectus and (ii) “issuer information,” as used
in this Section 5 shall not be deemed to include information prepared by such Placement Agent on
the basis of or derived from issuer information. The Placement Agent also agrees to provide to
each Investor, prior to the Closing, a copy of the Prospectus and any amendments or supplements
thereto.
6. Expenses. Whether or not the transactions contemplated by this Agreement are
consummated or this Agreement is terminated, the Company will pay all costs and expenses incident
to the performance of the obligations of the Company under this Agreement, including but not
limited to costs and expenses of or relating to (1) the preparation, printing and filing of the
Registration Statement (including each pre- and post-effective amendment thereto) and exhibits
thereto, any Issuer Free Writing Prospectus, each Preliminary Prospectus, the Prospectus and any
amendments or supplements thereto, including all fees, disbursements and other charges of counsel
and accountants to the Company, (2) the preparation and delivery of certificates representing the
Shares, (3) furnishing (including costs of shipping and mailing) such copies of the Registration
Statement (including all pre- and post-effective amendments thereto), the Prospectus and any
Preliminary Prospectus or Issuer Free Writing Prospectus, and all amendments and supplements
thereto, as may be requested for use in connection with the direct placement of the Shares, (4) the
listing of the Common Stock on the Nasdaq Capital Market, (5) any filings required to be made by
the Placement Agent with the NASD, and the fees, disbursements and other charges of counsel for the
Placement Agent in connection therewith, (6) the registration or qualification of the Shares for
offer and sale under the securities or Blue Sky laws of such jurisdictions designated pursuant to
Section 4(j), including the reasonable fees, disbursements and other charges of counsel to the
Placement Agent in connection therewith and the preparation and printing of preliminary,
supplemental and final Blue Sky memoranda, (7) fees, disbursements and other charges of counsel to
the Company, and (8) fees and disbursements of the Accountants incurred in delivering the letter(s)
described in 7(f) of this Agreement. Except as set forth herein, the Placement Agent shall pay its
own costs and expenses.
7. Conditions of the Obligations of the Placement Agent. The obligations of the
Placement Agent hereunder are subject to the following conditions:
(a) (i) No stop order suspending the effectiveness of the Registration Statement shall have
been issued, and no proceedings for that purpose shall be pending or threatened by any securities
or other governmental authority (including, without limitation, the Commission), (ii) no order
suspending the effectiveness of the Registration Statement or the
15
qualification or registration of the Shares under the securities or Blue Sky laws of any
jurisdiction shall be in effect and no proceeding for such purpose shall be pending before, or
threatened or contemplated by, any securities or other governmental authority (including, without
limitation, the Commission), (iii) any request for additional information on the part of the staff
of any securities or other governmental authority (including, without limitation, the Commission)
shall have been complied with to the satisfaction of the staff of the Commission or such
authorities and (iv) after the date hereof no amendment or supplement to the Registration
Statement, any Issuer Free Writing Prospectus or the Prospectus shall have been filed unless a copy
thereof was first submitted to the Placement Agent and the Placement Agent did not object thereto
in good faith, and the Placement Agent shall have received certificates of the Company, dated the
Closing Date and signed by the President and Chief Executive Officer or the Chairman of the Board
of Directors of the Company, and the Chief Financial Officer of the Company, to the effect of
clauses (i), (ii) and (iii).
(b) Since the respective dates as of which information is given in the Registration Statement
and the Prospectus, (i) there shall not have been a Material Adverse Change, whether or not arising
from transactions in the ordinary course of business, in each case other than as set forth in or
contemplated by the Registration Statement and the Prospectus and (ii) the Company shall not have
sustained any material loss or interference with its business or properties from fire, explosion,
flood or other casualty, whether or not covered by insurance, or from any labor dispute or any
court or legislative or other governmental action, order or decree, which is not set forth in the
Registration Statement and the Prospectus, if in the judgment of the Placement Agent any such
development makes it impracticable or inadvisable to consummate the sale and delivery of the Shares
to Investors as contemplated hereby.
(c) Since the respective dates as of which information is given in the Registration Statement
and the Prospectus, there shall have been no litigation or other proceeding instituted against the
Company or any of its officers or directors in their capacities as such, before or by any Federal,
state or local court, commission, regulatory body, administrative agency or other governmental
body, domestic or foreign, which litigation or proceeding, in the reasonable judgment of the
Placement Agent, could have a Material Adverse Effect.
(d) Each of the representations and warranties of the Company contained herein shall be true
and correct in all material respects at the Closing Date, as if made on such date, and all
covenants and agreements herein contained to be performed on the part of the Company and all
conditions herein contained to be fulfilled or complied with by the Company at or prior to the
Closing Date shall have been duly performed, fulfilled or complied with in all material respects.
(e) The Placement Agent shall have received an opinion, dated the Closing Date, of DLA Xxxxx
Xxxxxxx Xxxx Xxxx US LLP, as counsel to the Company, in form and substance reasonably satisfactory
to the Placement Agent, with respect to the matters set forth in Exhibit C hereto.
16
(f) The Placement Agent shall have received an opinion, dated the Closing Date, of Xxxxxx
Xxxxxxx PLLC, as special counsel to the Company, in form and substance reasonably satisfactory to
the Placement Agent, with respect to the matters set forth in Exhibit D hereto.
(g) On the date hereof, the Accountants shall have furnished to the Placement Agent a letter,
dated the date of its delivery (the “Comfort Letter”), addressed to the Placement Agent and in form
and substance satisfactory to the Placement Agent and the Accountants, confirming that (i) they are
independent public accountants with respect to the Company within the meaning of the Act and the
Rules and Regulations; (ii) in their opinion, the financial statements and any supplementary
financial information included in the Registration Statement and examined by them comply as to form
in all material respects with the applicable accounting requirements of the Act and the Rules and
Regulations; (iii) on the basis of procedures, not constituting an examination in accordance with
generally accepted auditing standards, set forth in detail in the Comfort Letter, a reading of the
latest available interim financial statements of the Company, inspections of the minute books of
the Company since the latest audited financial statements included in the Prospectus, inquiries of
officials of the Company responsible for financial and accounting matters and such other inquiries
and procedures as may be specified in the Comfort Letter to a date not more than five days prior to
the date of the Comfort Letter, nothing came to their attention that caused them to believe that as
of a specified date not more than five days prior to the date of the Comfort Letter, there have
been any changes in the capital stock of the Company or any increase in the long-term debt of the
Company, in each case as compared with amounts shown in the latest balance sheet included in the
Prospectus, except in each case for changes, increases or decreases which the Prospectus discloses
have occurred or may occur or which are described in the Comfort Letter; and (iv) in addition to
the examination referred to in their reports included in the Prospectus and the procedures referred
to in clause (iii) above, they have carried out certain specified procedures, not constituting an
examination in accordance with generally accepted auditing standards, with respect to certain
amounts, percentages and financial information specified by the Placement Agent, which are derived
from the general accounting, financial or other records of the Company, as the case may be, which
appear in the Prospectus or in Part II of, or in exhibits or schedules to, the Registration
Statement, and have compared such amounts, percentages and financial information with such
accounting, financial and other records and have found them to be in agreement.
(h) At the Closing Date, there shall be furnished to the Placement Agent a certificate, dated
the date of its delivery, signed on behalf of the Company by each of the Chief Executive Officer
and the Chief Financial Officer of the Company, in form and substance satisfactory to the Placement
Agent to the effect that each signer has carefully examined the Registration Statement, the
Prospectus and the Pricing Disclosure Materials, and that to each of such person’s knowledge:
(i) (A) As of the date of such certificate, (x) the Registration Statement does not
contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein not misleading and
(y) neither the Prospectus nor the Pricing Disclosure
17
Materials contains any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading and (B) no event has
occurred as a result of which it is necessary to amend or supplement the Prospectus in order
to make the statements therein not untrue or misleading in any material respect.
(ii) Each of the representations and warranties of the Company contained in this
Agreement were, when originally made, and are, at the time such certificate is delivered,
true and correct in all material respects.
(iii) Each of the covenants required herein to be performed by the Company on or prior
to the date of such certificate has been duly, timely and fully performed and each condition
herein required to be complied with by the Company on or prior to the delivery of such
certificate has been duly, timely and fully complied with.
(iv) No stop order suspending the effectiveness of the Registration Statement or of any
part thereof has been issued and no proceedings for that purpose have been instituted or are
contemplated by the Commission.
(v) Subsequent to the date of the most recent financial statements in the Prospectus,
there has been no Material Adverse Change.
(i) The Shares shall be qualified for sale in such states as the Placement Agent may
reasonably request, and each such qualification shall be in effect and not subject to any stop
order or other proceeding on the Closing Date, as provided in Sections 3(b) and 3(y) above.
(j) The Company shall have furnished or caused to be furnished to the Placement Agent such
certificates, in addition to those specifically mentioned herein, as the Placement Agent may have
reasonably requested as to the accuracy and completeness at the Closing Date of any statement in
the Registration Statement or the Prospectus, as to the accuracy at the Closing Date of the
representations and warranties of the Company as to the performance by the Company of its
obligations hereunder, or as to the fulfillment of the conditions concurrent and precedent to the
obligations hereunder of the Placement Agent.
(k) The Placement Agent shall have received the letters referred to in Section 3(nn) and (oo)
hereof substantially in the form of Exhibits A and B.
8. Indemnification.
(a) The Company shall indemnify and hold harmless the Placement Agent, its directors,
officers, employees and agents and each person, if any, who controls the Placement Agent within the
meaning of Section 15 of the Act or Section 20 of the Exchange Act, from and against any and all
losses, claims, liabilities, expenses and damages, joint or several, (including any and all
investigative, legal and other expenses reasonably incurred in connection with, and any amount paid
in settlement of, any action, suit or proceeding or any
18
claim asserted), to which it, or any of them, may become subject under the Act or other
Federal or state statutory law or regulation, at common law or otherwise, insofar as such losses,
claims, liabilities, expenses or damages arise out of or are based on (i) any untrue statement or
alleged untrue statement made by the Company in Section 3 of this Agreement, (ii) any untrue
statement or alleged untrue statement of any material fact contained in (A) any Preliminary
Prospectus, the Registration Statement or the Prospectus or any amendment or supplement thereto,
(B) any Issuer Free Writing Prospectus or any amendment or supplement thereto or (C) any Permitted
Issuer Information used or referred to in any “free writing prospectus” (as defined in Rule 405)
used or referred to by the Placement Agent and (B) any application or other document, or any
amendment or supplement thereto, executed by the Company based upon written information furnished
by or on behalf of the Company filed in any jurisdiction in order to qualify the Shares under the
securities or Blue Sky laws thereof or filed with the Commission or any securities association or
securities exchange (each, an “Application”), or (iii) the omission or alleged omission to state in
any Preliminary Prospectus, the Registration Statement, the Prospectus or any Issuer Free Writing
Prospectus, or any amendment or supplement thereto, or in any Permitted Issuer Information or any
Application a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading; provided,
however, that the Company will not be liable to the extent that such loss, claim,
liability, expense or damage arises from the sale of the Shares in the public offering to any
person and is based on an untrue statement or omission or alleged untrue statement or omission made
in reliance on and in conformity with information relating to the Placement Agent furnished in
writing to the Company by the Placement Agent expressly for inclusion in the Registration
Statement, any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or in any
amendment or supplement thereto or in any Permitted Issuer Information or any Application (as set
forth in paragraph (b) above); and provided further, that such indemnity with respect to any
Preliminary Prospectus shall not inure to the benefit of the Placement Agent (or any person
controlling the Placement Agent) from whom the person asserting any such loss, claim, damage,
liability or action purchased Shares which are the subject thereof to the extent that any such
loss, claim, damage or liability (i) results from the fact that the Placement Agent failed to send
or give a copy of the Prospectus (as amended or supplemented) to such person at or prior to the
confirmation of the sale of such Shares to such person in any case where such delivery is required
by the Act and (ii) arises out of or is based upon an untrue statement or omission of a material
fact contained in such Preliminary Prospectus that was corrected in the Prospectus (or any
amendment or supplement thereto), unless such failure to deliver the Prospectus (as amended or
supplemented) was the result of noncompliance by the Company with Section 4(d). This indemnity
agreement will be in addition to any liability which the Company may otherwise have.
(b) The Placement Agent will indemnify and hold harmless the Company, each person, if any, who
controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act,
each director of the Company and each officer of the Company who signs the Registration Statement
to the same extent as the foregoing indemnity from the Company to the Placement Agent, but only
insofar as losses, claims, liabilities, expenses or damages arise out of or are based on any untrue
statement or omission or alleged untrue statement or omission made in reliance on and in conformity
with information
19
relating to the Placement Agent furnished in writing to the Company by the Placement Agent
expressly for use in the Registration Statement, any Preliminary Prospectus, the Prospectus or any
Issuer Free Writing Prospectus. This indemnity agreement will be in addition to any liability that
the Placement Agent might otherwise have. The Company acknowledges that, for all purposes under
this Agreement, the last paragraph on the cover page of the
Prospectus constitutes the only information
relating to the Placement Agent furnished in writing to the Company by the Placement Agent
expressly for inclusion in the Registration Statement, any Preliminary Prospectus or the
Prospectus.
(c) Any party that proposes to assert the right to be indemnified under this Section 8 will,
promptly after receipt of notice of commencement of any action against such party in respect of
which a claim is to be made against an indemnifying party or parties under this Section 8, notify
each such indemnifying party of the commencement of such action, enclosing a copy of all papers
served, but the omission so to notify such indemnifying party will not relieve it from any
liability that it may have to any indemnified party under the foregoing provisions of this Section
8 unless, and only to the extent that, such omission results in the forfeiture of substantive
rights or defenses by the indemnifying party. If any such action is brought against any
indemnified party and it notifies the indemnifying party of its commencement, the indemnifying
party will be entitled to participate in and, to the extent that it elects by delivering written
notice to the indemnified party promptly after receiving notice of the commencement of the action
from the indemnified party, jointly with any other indemnifying party similarly notified, to assume
the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after
notice from the indemnifying party to the indemnified party of its election to assume the defense,
the indemnifying party will not be liable to the indemnified party for any legal or other expenses
except as provided below and except for the reasonable costs of investigation subsequently incurred
by the indemnified party in connection with the defense. The indemnified party will have the right
to employ its own counsel in any such action, but the fees, expenses and other charges of such
counsel will be at the expense of such indemnified party unless (1) the employment of counsel by
the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified
party has reasonably concluded (based on advice of counsel) that a conflict exists (based on advice
of counsel to the indemnified party) between the indemnified party and the indemnifying party that
would prevent the counsel selected by the indemnifying party from representing the indemnified
party (in which case the indemnifying party will not have the right to direct the defense of such
action on behalf of the indemnified party) or (3) the indemnifying party has not in fact employed
counsel to assume the defense of such action within a reasonable time after receiving notice of the
commencement of the action, in each of which cases the reasonable fees, disbursements and other
charges of counsel will be at the expense of the indemnifying party or parties. It is understood
that the indemnifying party or parties shall not, in connection with any proceeding or related
proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other
charges of more than one separate firm admitted to practice in such jurisdiction at any one time
for all such indemnified party or parties. All such fees, disbursements and other charges will be
reimbursed by the indemnifying party promptly as they are incurred. The Company will not, without
the prior written consent of the Placement Agent (which consent will not be unreasonably withheld),
settle or compromise or consent to
20
the entry of any judgment in any pending or threatened claim, action, suit or proceeding in
respect of which indemnification has been sought hereunder (whether or not the Placement Agent or
any person who controls the Placement Agent within the meaning of Section 15 of the Act or Section
20 of the Exchange Act is a party to such claim, action, suit or proceeding), unless such
settlement, compromise or consent includes an unconditional release of the Placement Agent and each
such controlling person from all liability arising out of such claim, action, suit or proceeding.
An indemnifying party will not be liable for any settlement of any action or claim effected without
its written consent (which consent will not be unreasonably withheld).
(d) In order to provide for just and equitable contribution in circumstances in which the
indemnification provided for in the foregoing paragraphs of this Section 8 is applicable in
accordance with its terms but for any reason is held to be unavailable from the Company or the
Placement Agent, the Company and the Placement Agent will contribute to the total losses, claims,
liabilities, expenses and damages (including any investigative, legal and other expenses reasonably
incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding
or any claim asserted, but after deducting any contribution received by the Company from persons
other than the Placement Agent such as persons who control the Company within the meaning of the
Act or the Exchange Act, officers of the Company who signed the Registration Statement and
directors of the Company, who also may be liable for contribution) to which the Company and the
Placement Agent may be subject in such proportion as shall be appropriate to reflect the relative
benefits received by the Company on the one hand and the Placement Agent on the other. The
relative benefits received by the Company on the one hand and the Placement Agent on the other
shall be deemed to be in the same proportion as the total net proceeds from the offering (before
deducting Company expenses) received by the Company as set forth in the table on the cover page of
the Prospectus bear to the fee received by the Placement Agent hereunder. If, but only if, the
allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of
contribution shall be made in such proportion as is appropriate to reflect not only the relative
benefits referred to in the foregoing sentence but also the relative fault of the Company, on the
one hand, and the Placement Agent on the other, with respect to the statements or omissions which
resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well
as any other relevant equitable considerations with respect to such offering. Such relative fault
shall be determined by reference to whether the untrue or alleged untrue statement of a material
fact or omission or alleged omission to state a material fact relates to information supplied by
the Company or the Placement Agent, the intent of the parties and their relative knowledge, access
to information and opportunity to correct or prevent such statement or omission. The Company and
the Placement Agent agree that it would not be just and equitable if contributions pursuant to this
Section 8(d) were to be determined by pro rata allocation or by any other method of allocation
which does not take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or
action in respect thereof, referred to above in this Section 8(d) shall be deemed to include, for
purpose of this Section 8(d), any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this Section 8(d), the Placement Agent shall not be required to contribute any amount
in excess
21
of the fee received by it, and no person found guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Act) will be entitled to contribution from any person who was
not guilty of such fraudulent misrepresentation. For purposes of this Section 8(d), any person who
controls a party to this Agreement within the meaning of the Act or the Exchange Act will have the
same rights to contribution as that party, and each officer of the Company who signed the
Registration Statement will have the same rights to contribution as the Company, subject in each
case to the provisions hereof. Any party entitled to contribution, promptly after receipt of
notice of commencement of any action against such party in respect of which a claim for
contribution may be made under this Section 8(d), will notify any such party or parties from whom
contribution may be sought, but the omission so to notify will not relieve the party or parties
from whom contribution may be sought from any other obligation it or they may have under this
Section 8(d). No party will be liable for contribution with respect to any action or claim settled
without its written consent (which consent will not be unreasonably withheld).
9. Termination.
(a) The obligations of the Placement Agent under this Agreement may be terminated at any time
prior to the Closing Date, by notice to the Company from the Placement Agent, without liability on
the part of the Placement Agent to the Company if, prior to delivery and payment for the Shares, in
the sole judgment of the Placement Agent (i) trading in the Common Stock of the Company shall have
been suspended by the Commission or by the Nasdaq Capital Market, (ii) trading in securities
generally on the Nasdaq Capital Market shall have been suspended or limited or minimum or maximum
prices shall have been generally established on such system, or additional material governmental
restrictions, not in force on the date of this Agreement, shall have been imposed upon trading in
securities generally by such system or by order of the Commission or any court or other
governmental authority, (iii) a general banking moratorium shall have been declared by Federal or
New York State authorities, or (iv) any material adverse change in the financial or securities
markets in the United States or any outbreak or material escalation of hostilities or declaration
by the United States of a national emergency or war or other calamity or crisis shall have
occurred, the effect of any of which is such as to make it, in the sole judgment of the Placement
Agent, impracticable or inadvisable to market the Shares on the terms and in the manner
contemplated by the Prospectus.
(b) If this Agreement shall be terminated pursuant to any of the provisions hereof, or if the
sale of the Shares provided for herein is not consummated because any condition to the obligations
of the Placement Agent set forth herein is not satisfied or because of any refusal, inability or
failure on the part of the Company to perform any agreement herein or comply with any provision
hereof, the Company will, subject to demand by the Placement Agent, reimburse the Placement Agent
for all out-of-pocket expenses reasonably incurred in connection herewith.
10. No Fiduciary Duty. The Company acknowledges and agrees that in connection with
this offering, sale of the Shares or any other services the Placement Agent may be deemed to be
providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise, between
the parties or any oral representations or assurances previously or
22
subsequently made by the Placement Agent: (i) no fiduciary or agency relationship between the
Company and any other person, on the one hand, and the Placement Agent, on the other, exists; (ii)
the Placement Agent is not acting as an advisor, expert or otherwise, to the Company, including,
without limitation, with respect to the determination of the offering price of the Shares, and such
relationship between the Company, on the one hand, and the Placement Agent, on the other, is
entirely and solely commercial, based on arms-length negotiations; (iii) any duties and obligations
that the Placement Agent may have to the Company shall be limited to those duties and obligations
specifically stated herein; and (iv) the Placement Agent and its respective affiliates may have
interests that differ from those of the Company. The Company hereby waives any claims that the
Company may have against the Placement Agent with respect to any breach of fiduciary duty in
connection with this offering.
11. Notices. Notice given pursuant to any of the provisions of this Agreement shall
be in writing and, unless otherwise specified, shall be mailed or delivered (a) if to the Company,
at the office of the Company, 24 Xxxxx Xxxxx Xxxxxx Xxxxx, X.X. Xxx 000, Xxx Xxxxx, Xxxxxxxx 00000,
Attention: Xxxxxx X. Xxxxxxx, Xx., with copies to DLA Xxxxx Xxxxxxx Xxxx Xxxx US LLP, 0000
Xxxxxxxxx Xxxxx, Xxxxx 0000, Xxx Xxxxx, Xxxxxxxxxx 00000-0000, Attention: Xxxxxxx X. Xxxx, Esq., or
(b) if to the Placement Agent, at the office of Xxxxxxxx Curhan Ford & Co., 000 Xxxxxxxxxx Xxxxxx,
0xx Xxxxx, Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: Xxxxxxxx X. Xxxxx, with copies to
Xxxxxxxx & Xxxxxxxx LLP, 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx Xxxx, Xxx Xxxx 00000-0000, Attention:
Xxxxx X. Xxxxxxxxx, Esq. Any such notice shall be effective only upon receipt. Any notice under
Section 8 may be made by facsimile or telephone, but if so made shall be subsequently confirmed in
writing.
12. Survival. The respective representations, warranties, agreements, covenants,
indemnities and other statements of the Company and the Placement Agent set forth in this Agreement
or made by or on behalf of them, respectively, pursuant to this Agreement shall remain in full
force and effect, regardless of (i) any investigation made by or on behalf of the Company, any of
its officers or directors, the Placement Agent or any controlling person referred to in Section 8
hereof and (ii) delivery of and payment for the Shares. The respective agreements, covenants,
indemnities and other statements set forth in Sections 6 and 8 hereof shall remain in full force
and effect, regardless of any termination or cancellation of this Agreement.
13. Successors. This Agreement shall inure to the benefit of and shall be binding
upon the Placement Agent, the Company and their respective successors and legal representatives,
and nothing expressed or mentioned in this Agreement is intended or shall be construed to give any
other person any legal or equitable right, remedy or claim under or in respect of this Agreement,
or any provisions herein contained, this Agreement and all conditions and provisions hereof being
intended to be and being for the sole and exclusive benefit of such persons and for the benefit of
no other person except that (i) the indemnification and contribution contained in Sections 8(a) and
(d) of this Agreement shall also be for the benefit of the directors, officers, employees and
agents of the Placement Agent and any person or persons who control the Placement Agent within the
meaning of Section 15 of the Act or Section 20 of the Exchange Act and (ii) the indemnification and
contribution contained in Sections 8(b) and (d) of this Agreement shall also be for the benefit of
the directors of the
23
Company, the officers of the Company who have signed the Registration Statement and any person
or persons who control the Company within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act. No Investor shall be deemed a successor because of such purchase.
14. Applicable Law. The validity and interpretations of this Agreement, and the terms
and conditions set forth herein, shall be governed by and construed in accordance with the laws of
the State of New York, without giving effect to any provisions relating to conflicts of laws.
15. Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.
16. Entire Agreement. This Agreement constitutes the entire understanding between the
parties hereto as to the matters covered hereby and supersedes all prior understandings, written or
oral, relating to such subject matter.
24
Please confirm that the foregoing correctly sets forth the agreement between the Company and
the Placement Agent.
Very truly yours, AASTROM BIOSCIENCES, INC. |
||||
By: | ||||
Name: | ||||
Title: | ||||
Confirmed as of the date first
above mentioned:
above mentioned:
XXXXXXXX CURHAN FORD & CO.
By:
Name:
Title:
Name:
Title:
SCHEDULE 1
FREE-WRITING PROSPECTUS
SCHEDULE 2
SUBSIDIARIES
1. | Aastrom Biosciences, S.L. | |
2. | Aastrom Biosciences GmbH |
SCHEDULE 4
LOCK-UPS
1. | R. Xxxxxxx Xxxxxxxxx | |
2.
|
Xxxxx X. Cour | |
3.
|
Xxxxxx X. Xxxxxxx, Xx. | |
4.
|
Xxxxxx X. Xxxx | |
5.
|
Xxxxx X. Xxxxxxx | |
6.
|
Xxxxx X. Xxxx | |
7.
|
Xxxxx X. Xxxxx | |
8.
|
Xxxxxxx X. Xxxxxxxx | |
9.
|
Xxxx X. Xxxxxx | |
10.
|
Xxxxxx X. Xxxx | |
11.
|
Xxxxxxx X. Xxxxxxx | |
00.
|
Xxxxxx X. Xxxxx |
EXHIBIT A
April __, 2006
Xxxxxxxx Curhan Ford & Co.
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Ladies and Gentlemen:
The undersigned understands that you, as Placement Agent, propose to enter into a Placement
Agency Agreement (the “Placement Agency Agreement”) with Aastrom Biosciences, Inc., a Michigan
corporation (the “Company”), providing for an offering (the “Offering”) of Common Stock.
Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the
Placement Agency Agreement.
In consideration of the foregoing, and in order to induce you to act as Placement Agent in the
Offering, and for other good and valuable consideration receipt of which is hereby acknowledged,
the undersigned hereby agrees that, without the prior written consent of Xxxxxxxx Curhan Ford &
Co., the undersigned will not, during the period beginning on the date of the final prospectus
supplement relating to the Offering of the Shares and ending on the date 90 days after the date of
such final prospectus supplement, (1) offer, pledge, announce the intention to sell, sell, contract
to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock (including without limitation, Common Stock which may be deemed to be
beneficially owned by the undersigned in accordance with the rules and regulations of the
Securities and Exchange Commission and securities which may be issued upon exercise of a stock
option or warrant), or (2) enter into any swap or other agreement that transfers, in whole or in
part, any of the economic consequences of ownership of the Common Stock, whether any such
transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise. In addition, the undersigned agrees that, without the
prior written consent of Xxxxxxxx Curhan Ford & Co., it will not, during the period ending 90 days
after the date of the Prospectus, make any demand for or exercise any right with respect to, the
registration of any shares of Common Stock or any security convertible into or exercisable or
exchangeable for Common Stock.
Notwithstanding the foregoing, the restrictions set forth in clause (1) and (2) above shall
not apply to (a) transfers (i) as a bona fide gift or gifts to any charitable organization, (ii) as
a bona fide gift or gifts to any other entity or person, provided that the donee or donees thereof
agree to be bound in writing by the restrictions set forth herein, (iii) to any trust for the
direct or indirect benefit of the undersigned or the immediate family of the undersigned, provided
that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein,
and provided further that any such transfer shall not involve a disposition for value, or (iv) with
the prior written consent of Xxxxxxxx Curhan Ford & Co., or (b) the acquisition or exercise of any
stock option issued pursuant to the Company’s existing stock option plan, including any exercise
effected by the delivery or sale of shares of Common Stock of the Company held by
Xxxxxxxx Curhan Ford & Co.
April ___, 2006
Page 2
April ___, 2006
Page 2
the undersigned. For purposes of this Letter Agreement, “immediate family” shall mean any
relationship by blood, marriage or adoption, not more remote than first cousin.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to
make any transfer of securities if such transfer would constitute a violation or breach of this
Letter Agreement.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
The undersigned understands that, if the Placement Agency Agreement does not become effective,
or if the Placement Agency Agreement (other than the provisions thereof which survive termination)
shall terminate or be terminated prior to payment for and delivery of the Shares to be sold
thereunder, the undersigned shall be released from all obligations under this Letter Agreement.
This lock-up agreement shall be governed by and construed in accordance with the laws of the
State of New York, without regard to the conflict of laws principles thereof.
Very truly yours, [NAME OF OFFICER OR DIRECTOR] |
||||
By: | ||||
Title: | ||||
Accepted as of the date first set forth above: XXXXXXXX CURHAN FORD & CO. |
||||
By: | ||||
Name: | ||||
Title: | ||||
EXHIBIT B
Xxxxxxxx Curhan Ford & Co.
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
000 Xxxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Ladies and Gentlemen:
Reference is made to a Placement Agency Agreement (the “Placement Agency Agreement”), which
will be executed between Aastrom Biosciences, Inc., a Michigan corporation (the “Company”), and
Xxxxxxxx Curhan Ford & Co. (the “Placement Agent”).
In consideration of the Placement Agency Agreement, the undersigned hereby agrees not to,
without the prior written consent of the Placement Agent, offer, sell or otherwise dispose of any
shares, directly or indirectly, of the Company’s Common Stock, no par value per share (the “Common
Stock”), owned by the undersigned for a period of 60 days after the date of the Placement Agency
Agreement, except with respect to the issuance of (i) shares of Common Stock upon the exercise of stock
options and warrants outstanding as of the date hereof, (ii) shares
or stock options under any benefit plan of the Company, (iii) shares pursuant to the
Company’s Direct Stock Purchase Plan and (iv) securities of the Company, including stock options,
issued to a new Chief Executive Officer of the Company appointed after the date hereof (provided
that such securities shall be subject to the same restrictions as indicated in the lock-up
agreements between the Company and its directors and officers for the balance, if any, of the 90
period after the date of the Placement Agency Agreement).
It is understood that, if the Company notifies you that it does not intend to proceed with the
issuance and sale of Shares (as defined in the Placement Agency Agreement) pursuant to the
Placement Agency Agreement, if the Placement Agency Agreement does not become effective, or if the
Placement Agency Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Shares, the undersigned will be
released from its obligations under this letter agreement.
Dated: April __, 2006
Very truly yours, AASTROM BIOSCIENCES, INC. |
||||
By: | ||||
Name: | ||||
Title: | ||||
EXHIBIT C
Matters to be Covered in the DLA Xxxxx Xxxxxxx Xxxx Xxxx US LLP Legal Opinion
1. | The Company is in good standing as a foreign corporation, is duly licensed or qualified and has the corporate power and authority to own, lease and operate its properties and to conduct its business in each jurisdiction in which the nature of the activities conducted by it or the character of the assets owned or leased by it makes such licensing or qualification necessary. | ||
2. | The issuance of the Shares is not subject to any rights known to such counsel of any securityholder of the Company similar to any statutory preemptive rights of any securityholder of the Company. | ||
3. | Except as set forth in or otherwise contemplated by the Registration Statement or the Prospectus, to the knowledge of such counsel, no person has the right to require the Company or any of its Subsidiaries to register any securities for sale under the Act by reason of the filing of the Registration Statement with the Commission or by reason of the issuance and sale of the Shares, except for rights which have been waived. | ||
4. | The Placement Agency Agreement has been duly authorized, executed and delivered by the Company, constitutes a valid and binding agreement of the Company, and is enforceable against the Company in accordance with the terms thereof. | ||
5. | To the knowledge of such counsel, no stop order suspending the effectiveness of the Registration Statement has been issued under the Securities Act of 1933, as amended (the “Act”) and no proceedings for that purpose have been instituted or are pending or threatened by the Commission. | ||
6. | The Registration Statement, including the Prospectus, including each of the documents incorporated by reference therein, and each amendment or supplement to the Registration Statement and Prospectus, as the case may be, including the documents incorporated by reference therein, as of their respective effective or issue dates, or as of the dates they were filed with the Commission, as the case may be (other than the financial statements and supporting schedules included therein or omitted therefrom, as to which we express no opinion), complied as to form in all material respects with the requirements of the Act and the rules and regulations of the Commission promulgated thereunder (the “Rules and Regulations”) and the Exchange Act. | ||
7. | To the knowledge of such counsel, there is not pending or threatened in writing any action, suit, proceeding, inquiry or investigation, to which the Company or any of its Subsidiaries are parties, or to which the property of the Company or its Subsidiaries are subject, before or brought by any court or governmental agency or body, domestic or foreign, that is required to be disclosed in the Prospectus and is not adequately disclosed therein. |
8. | All descriptions in the Registration Statement and the Prospectus of contracts and other documents to which the Company is a party are accurate; to the knowledge of such counsel, there are no franchises, contracts, indentures, mortgages, loan agreements, notes, leases or other instruments required to be described or referred to in the Registration Statement or the Prospectus or to be filed as exhibits thereto other than those described or referred to therein or filed or incorporated by reference as exhibits thereto. | ||
9. | No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any domestic court or governmental authority or agency, domestic or foreign (other than under the Act and the Rules and Regulations, which have been obtained, or as may be required under the securities or blue sky laws of the various states, as to which we express no opinion) is necessary or required in connection with the due authorization, execution and delivery of the Placement Agency Agreement or for the offering, issuance, sale or delivery of the Shares. | ||
10. | The execution, delivery and performance of the Placement Agency Agreement and the consummation of the transactions contemplated therein and in the Registration Statement and the Prospectus (including the issuance and sale of the Shares to the Investors) and compliance by the Company with its obligations under the Placement Agency Agreement and in connection with the offering, issuance and sale of the Shares to the Investors do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default under, or permit the holders of any debt known to such counsel to require the repurchase or redemption of any such debt pursuant to, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to, agreements to which the Company is a party and which are known to such counsel (except for such conflicts, breaches, defaults, liens, charges or encumbrances that would not have a Material Adverse Effect), nor will such action result in any material violation of any applicable law, statute, rule, regulation, judgment, order, writ or decree, known to us, of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Company or any of its assets, properties or operations. | ||
11. | The Company is not, nor will be upon completion of the offering, an “investment company” or an entity “controlled” by an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended. |
In addition, such counsel shall state that while such counsel is not passing upon and does not
assume any responsibility for the accuracy, completeness or fairness of the statements contained in
the Registration Statement, the Prospectus or the Pricing Disclosure Materials, or any supplements
or amendments thereto, no facts have come to the attention of such counsel which have caused it to
believe that: (i) the Registration Statement or any amendments thereto, at the time the
Registration Statement or any such amendments became effective, contained an untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein not misleading; (ii) the Prospectus, as of the Closing, contained an
untrue statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading; or (iii) the documents and information comprising the Pricing Disclosure
Materials, if any, taken as a whole as of the effective time, contained an untrue statement of a
material fact or omitted to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading (it being
understood that in each case such counsel need express no belief as to the financial statements,
including the notes and schedules thereto, or any other financial or accounting information, or the
information regarding the Placement Agent or the method of distribution of the Shares included in
the Registration Statement, the Prospectus or the Pricing Disclosure Materials or any such
amendments or supplements thereto).
EXHIBIT D
Matters to be Covered in the Xxxxxx Xxxxxxx PLLC Legal Opinion
1. | The Company has been duly organized, and is validly existing as a corporation in good standing under the laws of the State of Michigan. | ||
2. | The Company has the corporate power and authority to enter into and perform its obligations under the Placement Agency Agreement. | ||
3. | The Shares have been duly authorized and, when issued and delivered by the Company pursuant to the Placement Agency Agreement against payment of the consideration set forth on the cover of the Prospectus, will be validly issued, fully paid and non-assessable. | ||
4. | The issuance of the Shares is not subject to any statutory preemptive right of any securityholder of the Company. | ||
5. | The statements in the Prospectus under the caption “Description of Capital Stock,” insofar as they purport to constitute summaries of the terms of the Company’s charter or by-laws or Michigan statutes, rules and regulations thereunder, constitute accurate summaries of the terms of such documents, statutes, rules and regulations in all material respects. | ||
6. | The execution, delivery and performance of the Placement Agency Agreement do not and will not result in any violation of the provisions of the charter or by-laws of the Company in effect on the date hereof. |